Literature DB >> 4007505

Studies on the use of desferrioxamine in experimental ocular siderosis produced by extrabulbar administration of iron.

K Gerkowicz, M Prost.   

Abstract

The objective of these studies was to find out whether iron administered extrabulbarly can penetrate inside the eyeball and whether this process can be checked by transconjunctival injections of desferrioxamine. Histological examination revealed that 12 months after the placing of iron in the orbit, an accumulation of the metal can be observed in the sclera, choroid, and retina of untreated animals. In the group of animals treated with desferrioxamine, iron did not penetrate into the eyeball, and only in some animals could its presence be found in superficial layers of the sclera. The possibility is discussed of using the drug for the treatment of conditions resulting from the presence of foreign bodies in the orbit.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4007505     DOI: 10.1007/bf02150954

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

1.  Intra-orbital foreign bodies.

Authors:  H Neubaure; R A Frowein; J G Schmidt; W Ruessmann
Journal:  Mod Probl Ophthalmol       Date:  1975

2.  Deferoxamine: effects on intravitreal iron.

Authors:  H B Gardner
Journal:  Exp Eye Res       Date:  1976-09       Impact factor: 3.467

3.  Transscleral ocular siderosis.

Authors:  P G Burch; D M Albert
Journal:  Am J Ophthalmol       Date:  1977-07       Impact factor: 5.258

4.  [Effect of foreign metal bodies in the orbit on the ocular tunics].

Authors:  V A Sinovich; E V Gudkova
Journal:  Vestn Oftalmol       Date:  1969 Jul-Aug

5.  Nonsurgical removal of corneal rust stains.

Authors:  M A Galin; L S Harris; G J Papariello
Journal:  Arch Ophthalmol       Date:  1965-11

6.  Nonsurgical removal of corneal rust stains. II. Clinical trials.

Authors:  L S Harris; M A Galin; T W Mittag
Journal:  Am J Ophthalmol       Date:  1971-04       Impact factor: 5.258

7.  Experimental investigations on the effect of desferrioxamine on the aqueous level of iron administered intraorbitally.

Authors:  K Gerkowicz; M Prost
Journal:  Ophthalmologica       Date:  1984       Impact factor: 3.250

8.  Treatment of experimental siderosis bulbi, vitreous hemorrhage, and corneal blood staining with deferoxamine.

Authors:  J B Wise
Journal:  Arch Ophthalmol       Date:  1966-05

9.  Desferrioxamine in ocular siderosis: a long-term electrophysiological evaluation.

Authors:  S S Declercq
Journal:  Br J Ophthalmol       Date:  1980-08       Impact factor: 4.638

10.  Lens opacities in thalassemia.

Authors:  S E Bloomfield; A L Markenson; D R Miller; C M Peterson
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1978 May-Jun       Impact factor: 1.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.